NEW DELHI, July 31. The George Institute for Global Health India today released an evidence gap map (EGM) that analysed 557 research studies conducted on leptospirosis in India. The analysis highlighted gaps in research for basic biomedical research, epidemiology (disease distribution and risk factors), diagnostic tests and prevention, management and control efforts to address the problem of Leptospirosis. The development of the evidence-gap map was supported by the Indian Council of Medical Research (ICMR) and is expected to inform future strategic decisions in the area of research.
Salt intake continues to be high in many countries across the world including India. New studies of salt intake levels from thirteen countries, including India, showed salt intake in all countries is well above the World Health Organization (WHO) recommendation of less than 5 gram per day. The implementation of population-based salt reduction strategies remains a challenge in many low and middle-income countries.
Limited access to essential medicines for treating chronic diseases is a major challenge in low and middle-income countries. Although India is the largest manufacturer of generic medicines, there is a paucity of information on availability, price and affordability of essential anti-cancer medicines used for treating childhood cancers.
The first-ever National Symposium on Evidence Synthesis for Medicine, Public Health and Social Development (NSES 2019) organised by The George Institute for Global Health, India and the Campbell Collaboration in the Capital concluded on Friday with a clarion call to young researchers, knowledge brokers and policy-makers to work together to usher in the evidence revolution and ensure that the fields of public health, medicine and social development are informed by good science.